Very happy to see this published- on the safety of research biopsies performed in early phase clinical trials + issues of genomics and informed consent https://t.co/PfG3clLZNH, co-authored with @DrABiondo and @ICR_London@royalmarsdenNHS Drug Development Unit team @FayUCCancerCr
Great team effort by the Drug Development Unit at @ICR_London@royalmarsdenNHS. A privilige to be a co-author of a phase I trial of a FR alpha targeted thymidylate synthase inhibitor CT900 presented at #ASCO2020.
ASCO abstract 6043 Thank you patients and research staff for all your efforts. Single agent activity of alpha folate receptor targeted TS inhibitor CT900 in medium and high folate receptor expressing HGSOC. @BanerjeeSusana@ICR_London@royalmarsdenNHS @cancerBRC @ECMC_UK#ASCO20
https://t.co/UIdFGwpi5t a true honour to be working with the author of this wonderfully written piece on the stress medical life can expose you to. Well done @DrAbhiPal
@RichardDawkins Stuff you never knew about tides: [Video: 13m]
https://t.co/PjbPGrIpbx
p.s. A full treatment of tides on Earth eluded both Galileo & Newton, until the the 19th century treatise "Tides and Kindred Phenomena" by George Howard Darwin. Yes, son of Charles.
"You can tell (them) they will need to fly to the moon (for a trial) and they will go on that trial for you". Poster display on how we can better help patients understand key aspects (time, safety, benefit) of early phase cancer trials at 12 pm in Hall 4 (1834P) today at #ESMO19